United Kingdom

People: Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

5:39pm BST
Change (% chg)

$0.04 (+2.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Oien, Jessica 

Ms. Jessica Oien J.D., is General Counsel, Secretary of the Company. She formerly served as vice president, compliance at Otonomy, Inc., where she developed and oversaw the commercial compliance program and was the legal lead for the commercial business. She served in similar roles at Pernix Therapeutics, Somaxon Pharmaceuticals, Inc. and Verus Pharmaceuticals. She provided legal consulting services for a robust clientele of early-stage biotech companies including legal support for numerous collaborations, and research and development programs. Oien also served as senior director, legal affairs at Elan Corporation. She began her legal career as outside corporate counsel at national law firms including tenures at Brobeck, Phleger & Harrison and Millbank, Tweed, Hadley & McCloy. Oien holds a Juris Doctorate degree from Loyola Law School and a Bachelor of Arts degree in Economics and Political Science from North Dakota State University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --